Skip to main content
Retour
Watch Compare

Glucose Health, Inc.

Qualité des données : 100%
GLUC
OTC Manufacturing Chemicals
0,39 €
▼ 0,01 € (-2,50%)
Cap. Boursière: 7,71 M
Prix
0,44 €
Cap. Boursière
7,71 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -17 253,0

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)7232,14%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net Margin-96,52%
Op. Margin-36,82%

Sécurité

Debt / Equity
N/A
Current Ratio0,06
Interest Coverage-0,29

Valorisation

PE (TTM)
-90,68
En dessous de la moyenne du secteur (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -90,7 -1,5
P/B — 1,6
ROE % — -53,5
Net Margin % -96,5 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

All Fundamental Metrics
Growth
Revenue Growth (1Y) 7232,14% Revenue Growth (3Y) 969,39%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 88 130,0 Net Income (TTM) -85 062,0
ROE N/A ROA -316,98%
Gross Margin 65,39% Operating Margin -36,82%
Net Margin -96,52% Free Cash Flow (TTM) -17 253,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,06
Interest Coverage -0,29 Asset Turnover 3,28
Working Capital -426 427 Tangible Book Value -426 232
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -90,68 Forward P/E N/A
P/B Ratio N/A P/S Ratio 87,52
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0,22%
Market Cap 7,71 M Enterprise Value 7,70 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0,01
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 20,28%
SBC-Adj. FCF -18 159 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2016 FY2015 FY2014 FY2013 FY2012
Revenue 313 229,0 4 272,0 2 739,0 -224,0 —
Net Income -410 443,0 -266 064,0 -669 409,0 -2,03 M -568 650,0
EPS (Diluted) — — — — —
Gross Profit 19 167,0 397,0 -20 725,0 -5 723,0 -3 632,0
Operating Income -86 647,0 -156 173,0 -545 216,0 -1,80 M -532 479,0
EBITDA — — — — —
R&D Expenses 48,0 48,0 4 000,0 — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 323 796,0 120 028,0 109 631,0 205 033,0 36 171,0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2016 FY2015 FY2014 FY2013 FY2012
Total Assets 33 145,0 15 407,0 44 030,0 25 590,0 207 676,0
Total Liabilities 528 592,0 403 226,0 324 582,0 223 348,0 185 476,0
Shareholders' Equity -495 447,0 -387 819,0 -280 552,0 -197 758,0 22 200,0
Total Debt — — — — —
Cash & Equivalents 20 542,0 2 055,0 711,0 1 076,0 82,0
Current Assets 32 905,0 15 107,0 43 730,0 25 590,0 1 076,0
Current Liabilities 528 592,0 403 226,0 324 582,0 223 348,0 185 476,0